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Abstract
Background: Mercury is known to bioaccumulate and to magnify in marine mammals, which is a cause of great concern
in terms of their general health. In particular, the immune system is known to be susceptible to long-term mercury
exposure. The aims of the present study were (1) to determine the mercury level in the blood of free-ranging harbour
seals from the North Sea and (2) to examine the link between methylmercury in vitro exposure and immune functions
using seal and human mitogen-stimulated peripheral blood mononuclear cells (T-lymphocytes).
Methods: Total mercury was analysed in the blood of 22 harbour seals. Peripheral blood mononuclear cells were
isolated from seals (n = 11) and from humans (n = 9). Stimulated lymphocytes of both species were exposed to functional
tests (proliferation, metabolic activity, radioactive precursor incorporation) under increasing doses of methylmercury
(0.1 to 10 μM). The expression of cytokines (IL-2, IL-4 and TGF-β) was investigated in seal lymphocytes by RT-PCR and
by real time quantitative PCR (n = 5) at methylmercury concentrations of 0.2 and 1 μM. Finally, proteomics analysis was
attempted on human lymphocytes (cytoplasmic fraction) in order to identify biochemical pathways of toxicity at
concentration of 1 μM (n = 3).
Results: The results showed that the number of seal lymphocytes, viability, metabolic activity, DNA and RNA synthesis
were reduced in vitro, suggesting deleterious effects of methylmercury concentrations naturally encountered in free-
ranging seals. Similar results were found for human lymphocytes. Functional tests showed that a 1 μM concentration was
the critical concentration above which lymphocyte activity, proliferation and survival were compromised. The expression
of IL-2 and TGF-β mRNA was weaker in exposed seal lymphocytes compared to control cells (0.2 and 1 μM). Proteomics
showed some variation in the protein expression profile (e.g. vimentin).
Conclusion: Our results suggest that seal and human PBMCs react in a comparable way to MeHg in vitro exposure with,
however, larger inter-individual variations. MeHg could be an additional cofactor in the immunosuppressive pollutant
cocktail generally described in the blood of seals and this therefore raises the possibility of additional additive effects in
the marine mammal immune system.
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Mercury (Hg) is a widely present metal in the environ-
ment, with a major natural source being provided by
degassing from the Earth's crust [1,2]. Its environmental
level has also increased as a consequence of discharge
from various industries, from medical and scientific
waste, and from the processing of raw ores [1,2]. Follow-
ing the discovery in the early 1960s of the dangers to
human health of Hg in the marine environment, there has
been a steady reduction in the man-made discharge of Hg
[3]. However, despite these regulations, a decrease in lev-
els of mercury in the biota, including marine mammals, is
not obvious [3-6].
Methylation of inorganic Hg is a key processes in marine
food webs affected by several variables including temper-
ature [7-10]; It raises serious concerns in the light of glo-
bal change and increasing seawater temperature [9,10].
MeHg has a high bioavailability; it bioaccumulates and
biomagnifies at all trophic levels in the food web and has
severe toxicological effects [11,12]. Fish represent the
major MeHg source for human and marine mammal pop-
ulations [13-17].
High Hg concentration have been documented in the liver
and kidney of marine mammals (from both pristine and
contaminated areas), generally associated to Se in a non
organic form (tiemannite or HgSe) [18-21]. The high rel-
evance of tiemannite precipitation in marine mammals
(compared to other mammals and birds) is likely to be
related to a combination of factors, namely, elevated
MeHg exposure, due to fish eating habits, and the inabil-
ity to excrete MeHg through gills, feathers or fur [21-24].
However, the demethylation process is not "instantane-
ous" and before reaching these long-term accumulation
organs, Hg is assimilated from fish, and is transferred and
transported via the blood stream, mainly in its methylated
form [11,12]. A high percentage of blood Hg concentra-
tion is in a methylated form (up to 90%), especially in
human and marine mammal populations relying on fish
[11,12,25] and so may represent a threat towards blood
cells, including immune cells.
It has been suggested that impairment of immune func-
tion plays a contributing role in the increasing incidence
of infectious diseases in marine mammals. Moreover,
adverse effects of environmental contaminants on the
immune system have often been suggested [26-29]. Infor-
mation on the immune system of harbour seals is quite
well documented. This species has conveniently become
the marine mammal of choice for immunological studies
[27,28]. Interest in the harbour seal has stemmed partly
from earlier captive studies on the reproductive toxicity of
environmental contaminants using this species [30], but
more importantly this interest has occurred as a conse-
quence of recurrent phocine distemper virus (PDV) epiz-
ootics [31-33]. However, despite numerous studies
involving the in vivo and in vitro effects of persistent
organic pollutants [29,34-44], information on the effects
of Hg on the marine mammal immune system and under-
lying mechanisms remains scarce [45-48].
The aims of the present study were (1) to determine T-Hg
levels in the blood of free-ranging harbour seals from the
North Sea and (2) to examine the link between in vitro Hg
exposure at low doses and immune functions using seal
and human mitogen-stimulated peripheral blood mono-
nuclear cells (PBMCs). Seals and humans were exposed in
vitro, using various MeHg concentrations (0.1 to 10 μM),
reflecting the levels encountered in wildlife. MeHg was
chosen as it is the predominant form in the blood of
marine mammals and fish-eating communities
[12,17,49]. We assessed the effects of MeHg on T-cell via-
bility and the proliferative response to mitogen of periph-
eral lymphocytes in both harbour seals and humans. We
also examined the effect of MeHg on the in vitro produc-
tion by seal PBMCs of cytokines IL-2, IL-4 and TGF-β(0.2
and 1 μM). Finally, we attempted through the use of pro-
teomics analysis, to delineate the biochemical pathways
of MeHg in in vitro exposure (1 μM) using a first human
PBMC model.
Methods
Blood sampling
Blood was sampled from 33 harbour seals caught along
the German coast or kept in captivity (Seal Station, Frie-
drichskoog, Germany) between 1997 and 2006 (Table 1).
The seals were physically restrained. Health status was
determined by physical examination, using routine hae-
matological analysis (blood counts) and serum chemistry
(detailed protocol described previously [50]).
Blood was drawn from the extradural venous sinus into
sterile evacuated blood collection Monovette® tubes
(serum tubes for Hg analysis, EDTA tubes for RT-PCR and
heparinised tubes for functional tests and proteomics
analysis). Blood tubes were kept at -20°C until Hg analy-
sis or were processed within 18 hours for cell cultures.
Buffy coats from healthy 30–60 year old male humans (n
= 9) were integrated into this study for the PBMC culture
(Croix Rouge de Belgique).
Mercury analysis
The measurement of the concentration of T-Hg in blood
is generally a good surrogate for the concentration of
MeHg in blood in human populations with a high fish
consumption [12,16]. T-Hg was analysed in full blood
from 22 harbour seals by cold vapour atomic absorptionPage 2 of 17
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cury Analyser (wavelength 253.7 nm). The freeze-dried
samples were subjected to microwave-assisted digestion
with nitric acid and H2O2, as described previously for
blood and other tissues [51,52]. Quality control measure-
ments for T-Hg included replicate analysis resulting in
coefficients of variation < 10% and analysis of certified
material (DORM-1, NRC, Canada). The Hg absolute
detection limit was 10 ng, corresponding to 0.13 μg.g-1
fresh weight (fw) for an average of 1.5 g of sample ana-
lysed. All samples were above the detection limit.
Cell cultures
Harbour seals
The blood was diluted 1:2 with phosphate-buffered saline
(PBS). Lymphocytes were separated on a Ficoll gradient
(Pashing and Amersham), washed twice in PBS and sus-
pended in culture medium containing 10% foetal calf
serum (Minimum essential Medium, Eagle for cytokine
expression and RPMI 1640 Cambrex added with 1% L-
glutamine and 10% penicillin-streptomycin for func-
tional tests). PBMCs were incubated without mitogen or
in the presence of phytohemaglutinin (PHA, 5 μg.ml-1), a
T-cell-specific mitogen [42,53]. 2 × 105 cells were seeded
in a final volume of 300 μl per well (for cytokine expres-
sion) or 100 μl per well (functional tests). To some of
these wells, CH3HgCl (Sigma-Aldrich) was added in dif-
ferent concentrations (0.1 to 10 μM depending on the
assay). Cells were then incubated for 72 h at 37°C with
5% CO2.
Humans
PBMCs were isolated from buffy coats by using standard
Ficoll/Hypaque (Amersham) gradients and were washed
twice in PBS. The pellet was suspended in the culture
medium (RPMI 1640 supplemented with 10% heat inac-
tivated foetal bovine serum (in vitrogen), 1% L-
glutamine, 10% penicillin-streptomycin; Cambrex). 2 ×
Table 1: Sampling description of harbour seal Phoca vitulina
ID Date Sampling site Sex Length (cm) Body mass (kg) Assay
Pv 455 20/10/97 Lorenzensplate M 117 32 T-Hg
Pv 456 20/10/97 Lorenzensplate F 104 30 T-Hg
Pv 460 20/10/97 Lorenzensplate M 133 49 T-Hg
Pv 2257 09/04/03 Lorenzensplate M 144 68 T-Hg
Pv 2258 09/04/03 Lorenzensplate M 148 63 T-Hg
Pv 2259 09/04/03 Lorenzensplate F 129 38 T-Hg
Pv 2260 09/04/03 Lorenzensplate F 143 48 T-Hg
Pv 2261 09/04/03 Lorenzensplate F 158 56 T-Hg
Pv 2262 09/04/03 Lorenzensplate F 132 46 T-Hg
Pv 2263 09/04/03 Lorenzensplate F 148 55 T-Hg
Pv 2265 09/04/03 Lorenzensplate F 148 55 T-Hg
Pv 2687 25/08/04 Lorenzensplate M 170 84 T-Hg
Pv 2688 25/08/04 Lorenzensplate M 170 82 T-Hg
Pv 2689 25/08/04 Lorenzensplate M 175 80 T-Hg
Pv 2690 25/08/04 Lorenzensplate M 175 90 T-Hg
Pv 2691 25/08/04 Lorenzensplate F 150 58 T-Hg
Pv 2692 25/08/04 Lorenzensplate F 165 70 T-Hg
Pv 2694 25/08/04 Lorenzensplate M 160 75 T-Hg
Pv 2695 25/08/04 Lorenzensplate M 175 87 T-Hg
Pv 2697 25/08/04 Lorenzensplate F 135 42 T-Hg
Pv 2699 25/08/04 Lorenzensplate M 140 40 T-Hg
Pv 2700 25/08/04 Lorenzensplate M 125 39 T-Hg
Kirsa 28/02/05 Seal station F nd 28 Cytokine
Pv 2883 12/04/05 Lorenzensplate M 174 93 Cytokine
Pv 2885 12/04/05 Lorenzensplate M 168 81 Cytokine
Pv 2887 12/04/05 Lorenzensplate M 180 96 Cytokine
Pv 2893 12/04/05 Lorenzensplate M 164 71 Cytokine
Lümmen 31/03/2006
30/07/2006
Seal station M nd 105 Functional tests
Hein 31/03/2006
30/07/2006
Seal station M nd 86 Functional tests
Deern 31/03/2006 Seal station F nd 70 Functional tests
Lilli 28/04/2006 Seal station F nd 54 Functional tests
Mareike 28/04/2006 Seal station F nd 66 Functional tests
Kirsa 28/04/2006 Seal station F nd 35 Functional testsPage 3 of 17
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96-well microculture plate (Falco, New Jersey, USA). For
proteomics analysis, 20 ml were deposited in T75 flasks
(Susp Cell Ven green, Sarsted). PHA was diluted in culture
medium at an optimal concentration of 1 μg.ml-1 [54].
Cytokine expression
The expression of the housekeeping gene glyceraldehyde-
3-phosphate (GAPDH), of interleukins-IL-2 and IL-4 and
of the transforming growth factor (TGF)-β was investi-
gated in vitro in control and contaminated seal PBMCs (n
= 6, Table 1) using RT-PCR and real time PCR, as
described elsewhere [53,55,56]. For a quantitative analy-
sis of mRNA expression, a comparison between samples
can be made by relating gene expression levels to house-
keeping gene expression, the latter regarded as being unaf-
fected by exposure conditions. After the incubation period
(72 h), total RNA was isolated from exposed and control
PBMCs (RNeasy® Mini Kit, Qiagen Sciences, Maryland,
USA) following the manufacturer's recommendations.
After DNase-treatment (DNA-free™, Ambion kit), RNA
was reverse transcribed with murine reverse transcriptase
(RNA PCR Core Kit™, Applied Biosystems, Weiterstadt,
Germany) and the resulting cDNA served as a template for
PCR following the manufacturer's protocol and using
Thermocycler MX4000™ (Stratagene Europe). For real-
time quantification, the Brilliant SYBRGreen QPCR Mas-
ter mix (Stratagen Europe) was used [56]. This contained
SYBRGreen I as a fluorescence dye, dNTPs, MgCl2 and a
hot start Taq DNA polymerase. Primers for the PCR were
designed using DNAstarTM software (GATC Biotech, Kon-
stanz, Germany). Primers for the detection of IL-2 and IL-
4 were selected from conserved nucleotide sequences of
grey seals (Halichoerus grypus) and dogs (Canis familiaris)
respectively (GenBank accession numbers AF072871,
AF187322, AF104245). Primer sequences for the amplifi-
cation of GAPDH and TGF-β were selected from previ-
ously published sequences [53] (Table 2).
The fluorescence response was monitored in a linear fash-
ion, as the PCR product was generated over a range of PCR
cycles. For each cytokine, a standard curve was prepared
using a dilution series from 109 to 102 copies. The PCR
started with an initial step at 95°C for 10 min, followed
by 40 cycles with denaturation at 95°C for 1 min, anneal-
ing temperature for 30 sec and elongation at 72°C for 1
min. The fluorescence was measured at the end of the
annealing and at the end of the dissociation program at a
wavelength of 530 nm. In order to exclude measurement
of non specific PCR products and primer dimers, and to
determine true amplification, each PCR was followed by a
dissociation program for 1 min at 95°C, followed by 41
cycles during which the temperature was increased in each
cycle, starting at 55°C and ending at 95°C. Only PCR
reactions with one well-defined peak were used for analy-
sis. All reactions were performed in duplicate and two sep-
arate PCR reactions were performed. GAPDH was used as
the control gene. In order to calculate cytokine expression,
GAPDH was used as the calibration compound. The
cytokine expression index (CI) was calculated as follows:
CI = Number of cytokine copies/Number of GAPDH copies
Viability of PBMCs and functional tests
The viability and number of PHA-stimulated PBMCs were
determined microscopically by trypan blue exclusion
assay and a haemocytometer before and after MeHg expo-
sure.
MTS assay
After 72 hours of MeHg exposure (0.1, 0.2, 0.5, 1, 1.5, 5,
10 μM), the metabolic activity of the cells was quantified
by a colorimetric microtitre plate MTS assay 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulphophenyl)-2H-tetrazolium, inner salt (MTS,
Promega), according to the manufacturer's instructions.
10 μl of prepared MTS solutions were added to the 100 μl
culture medium containing the cells. MTS is chemically
reduced by cells into formazan, which is soluble in culture
Table 2: Primer sequences used for the amplification of cytokine and housekeeping gene transcripts in lymphocytes
Gene Primer sequence (5'-3') Direction Annealing 
temperature
Nucleotide 
position
Calculated 
length of 
amplicon
Sequences used for 
primer pair selection 
(accession number, 
NCBI)
IL-2 TTT AAG TTT TAC ACG CCC AAG
TGT TTC AGA TCC CTT TAG TTTC
S
AS
55°C 218–400 183 pb AF072871
IL-4 ACT CAC CAG CAC CTT TGT CCA
TCC TTA TCG CTT GTT CTT TG
S
AS
49°C 48–200 153 pb AF187322, AF104245
TGF-β TTC CTG CTC CTC ATG GCC AC
GCA GGA GCG CAC GAT CAT GT
S
AS
57°C 826–845
1218–1199
393 pb [51]
GAPDH GCC AAA AGG GTC ATC ATC TC
GGG GCC ATC CAC AGT CTT CT
S
AS
57°C 1225–1244
1452–1433
228 pb [51]
bp = base pair; S = sense; AS = antisense; IL = interleukin; TGF = transforming growth factorPage 4 of 17
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measurement of the absorbance of the formazan was car-
ried out on a spectrophotometer (Powerwave X, Bio-Tek)
at 492 nm. Each condition was produced in 5 wells.
Incorporation of radioactive precursors
DNA, RNA and protein synthesis were determined by
measuring the amount of incorporated radioactive precur-
sors using a scintillation counter. 2 × 105 cells were seeded
in 200 μl culture medium. During the last 24 h of culture,
1 μCi.ml-1 of methyl-[3H] thymidine (specific activity 20–
40 Ci.mmole-1), [3H] uridine (specific activity 20–40
Ci.mmole-1) or [3H] L-leucine (specific activity 40–60
Ci.mmole-1, MP Biomedicals) was added to each well and
cellular incorporation was determined. Cells were har-
vested on a filter (Multiscreen HTS, Millipore) with a mil-
lipore aspiration system, as described by the
manufacturer's instructions. The following steps were car-
ried out with an automatic dispenser (Precision Power
2000): 100 μl PBS, 120 μl trypsin 10 min, 100 μl PBS, 100
μl ethanol 20 min, 3× 100 μl ethanol. The plates were
dried overnight, and the filters were collected in vials
(Puncher Millipore). 400 μl sodium hypochlorite (1:10
v:v) were then added. After 30 min agitation, 4 ml scintil-
lating liquid (Ready Safe, Beckman) were added and
quantification of the retained radioactivity by the cells
was made by liquid scintillation in a counter (LS 6500
Scintillation system, Beckman). Results from triplicates
(means of counts per minute ± standard deviations) are
expressed in percentages (control taken to be 100%).
Proteomics analysis
Preliminary proteomics analysis (the study of the pro-
teome) was carried out on human PBMCs. We focus this
part of the study on cytoplasmic fraction (soluble pro-
teins). Cells were treated with 1 μM MeHgCl in the pres-
ence of PHA for 72 h. Quantitative analysis was carried
out on 2D DIGE gels in two steps. First, individuals were
treated separately (n = 3) in order to discover interindivid-
ual variability and secondly, individuals were pooled in
order to obtain sufficient amount of proteins to run the
gel.
Protein preparation
After 72 h of MeHg exposure (1 μM), cells were harvested
with PBS. Subcellular perfractionation was performed to
isolate cytosolic proteins, as described previously [57].
Cytosolic proteins were extracted in a hypotonic buffer
(10 mM HEPES, pH 7.4; 10 mM NaCl; KH2PO4 1 mM,
NAHCO3 5 mM, EDTA 5 mM, CACl2 (H2O)2 1 mM,
MgCl2 (H2O)6 0.5 mM and EDTA-free antiproteases
(Roche Molecular Biochemicals) followed by centrifuga-
tion. Pellets were suspended in isotonic buffer (sucrose,
2.5 M) before two centrifugation steps at 6300 g (elimina-
tion of nucleus and large size cellular fragments) and
107,000 g (elimination of organites and membranes).
The different extracts were purified using the 2D Clean-Up
Kit (according to the manufacturer's instructions). After
this purification step, each sample was redissolved in the
DIGE buffer (urea 7 M, thiourea 2 M, Tris-HCl pH 8.8 30
mM, Chaps 1.5%, ABS-14 1.5%). After a second assay,
allowing us to discover the exact concentration of our
extracts, the samples were diluted to a protein concentra-
tion of 5 μg.μl and to pH 8, using DIGE buffer. A Mowse
score (MOlecularWeightSEarch) was calculated, based on
peptide frequency distribution [58].
Protein separation
After extraction, the variations in protein abundance
between the treated (with 1 μM of MeHg) and non-treated
samples were measured using the 2D DIGE technique
(Two Dimension Difference Gel Electrophoresis).
The labelling of both the control fraction (12.5 μg), and
the exposed fractions (12.5 μg) was carried out with 100
pmol of Cye 3 and of Cye 5 respectively. The internal
standard consisted of a mixture of each sample (12.5 μg
per sample) labelled with 1200 pmol of Cye 2. This step
was then followed by incubation on ice for 45 minutes in
the dark. The eventual excess of Cye was eliminated by the
addition of 10-4 mol of lysine on ice for 15 minutes in the
dark. The labelled samples were pooled. In addition 150
μg of unlabelled protein were added to achieve a sufficient
quantity of unlabelled protein required for analysis by
mass spectrometry. A volume of buffer 2× (urea 7 M,
thiourea 2 M, chaps 1.5%, ASB-14 1.5%, destreak reagent
12.5 μl.ml-1, DTT 10 mM, ampholyte 1%) was added in
equivalent quantities to the previously pooled samples.
The final volume of the samples was brought up to 450 μl
with IEF buffer (urea 7 M, thiourea 2 M, chaps 1.5%, ASB-
14 1.5%, destreak reagent 12.5 μl.ml-1, ampholyte 0.5%,
bromophenol blue 0.5%).
The measurement of the first dimension of the gel was car-
ried out on gel strips with a fixed pH gradient (Immo-
biline DryStrip) in an electrical focalisation cell (Protean
IEF cell, Bio-Rad). After active rehydration for 9 h with the
sample, isoelectric focalisation was carried out up to
50,000 Vh overnight. Before the second dimension was
measured, reduction buffer was added for 15 minutes
(DTT 130 mM, urea 6 M, Tris-HCl pH 8.8 0.373 M, glyc-
erol 20%v/v, SDS 2%w/v) followed by the addition of an
alkylation buffer for 15 minutes (iodoacetamide 135 mM,
urea 6 M, Tris-HCl pH 8.8 0.373 M, glycerol 20%v/v, SDS
2%w/v).
The measurement of the second dimension was carried
out overnight after depositing the strips on a 12.5% poly-
acrylamide gel (Tris-HCl pH 8.8 1.5 M, SDS 0.4%w/v, acr-
ylamide/bisacrylamide 40%, ammonium persulphatePage 5 of 17
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then placed on non-fluorescing (Bind-Silane) plates
(Ettan-DALT "Low Fluorescence" Casting Cassette, Amer-
sham Biosciences). After migration, the gels were scanned
at the three different wave lengths of the cyanines (Cye2
520 nm bandwidth 40, Cye3 580 nm Bp 30, Cye5 670 nm
Bp 30) using a Typhoon 9400 (Amersham Biosciences),
with a resolution of 100 μm. The images obtained were
analysed using a software program (Decyder 6.0, Amer-
sham Biosciences). Only the regulations ± 1.5 above the
standard deviation were taken into account and compared
with a T Student value at a 95% confidence level.
Mass spectrometry protein identification
The spots of interest, selected using the software program
were excised from the gel, by a spot picker (Ettan Spot
Picker, Amersham Biosciences), and were then placed in
96 well plates for enzymatic digestion (Proteineer dp
automated digester, Bruker). The peptides resulting from
the digestion were spotted onto a prespotted MALDI plate
(AnchorChips, Bruker). The proteins were identified using
an Ultraflex MALDI TOF/TOF (Bruker). The mass values
from the mass fingerprints, and from the MS/MS spectra
were processed within different data bases (Sprot, NCBI,
MSDB). The search engine used was MASCOT, using the
following parameters: the mass tolerance for peptides was
set at ± 60 ppm, the charge state at 1+ and the maximum
number of missed cleavages at 1.
Data analysis
Student's t-test was used for comparing control and
MeHg-treated cells.
Results
Hg levels in the blood of free-ranging seals
T-Hg levels in full blood varied from 0.04 to 0.56 μg.g-1 fw
(43 to 611 μg Hg.L-1) with a mean concentration of 0.16
μg.g-1 fw (Table 3). T-Hg concentrations were found to be
similar between males and females (Student's t-test, p >
0.5) and individuals were therefore regrouped. T-Hg con-
centration in blood was found to be significantly corre-
lated to the body mass (rp = 0.59 and p < 0.001) and
length of the seals (rp = 0.60 and p < 0.001) (Figure 1).
Proliferative response of controls and exposed human and 
seal PBMCs
The PHA-induced proliferative responses of PBMCs col-
lected from seals and humans are shown in Figure 2. A sig-
nificant decrease in the percentage of lymphocyte
proliferation was found at MeHg concentrations of 5 and
10 μM in both seals and humans (Figure 3). Cell mortality
was found to be moderate at 1 and 1.5 μM of MeHg.
Functional tests
A decrease in DNA, RNA and protein synthesis was
observed even at low MeHg concentrations (0.2 and 1
μM), whereas inhibition of synthesis was clearly noticed
at 10 μM (Figure 4). DNA, RNA and protein synthesis
showed a similar profile but nucleic acid synthesis seemed
more inhibited compared to proteins. After 48 h, the con-
centrations inhibiting 50% of DNA and RNA synthesis of
the two species were found to be around 1 μM and 1.5
μM, while the 50% protein synthesis inhibiting concen-
tration was found to be around 1.5 μM.
Table 3: Total Hg concentrations in blood of pinniped species
Species Location, year Condition Reference Concentration
μg.L-1 μg.g-1 fw
Phoca vitulina North Sea.
(1997–2004)
Free-ranging seals this work 172 ± 143
(43–611)
n = 22
0.16 ± 0.13
(0.04 – 0.56)
n = 22
Phoca groenlandica NW Atlantic Captive seal
(before MeHg exposure)
[61] 80 ± 40
(n = 6)
nd
Phoca groenlandica Gulf of St Lawrence
(1976 – 1978)
Free-ranging adult seals [62] nd Males: 0.15 ± 0.02
n = 2
Females: 0.07 ± 0.04
n = 48
Phoca groenlandica Front ice off Newfoundland – Labrador
(1976–1978)
Free-ranging adult seals [62] nd Males: 0.04 ± 0.02
n = 3
Females: 0.02
n = 1
Leptonychotes weddellii Antarctic
1980
Free-ranging seals [63] nd 0.02
n = 2
Callorhinus ursinus Alaska, 1972 Wild nursing cows [85] nd 0.099
n = 2
mean ± standard deviation, n = number of samples analysed, nd = not determinedPage 6 of 17
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Relationship between body mass (graph on top) and length (graph on the bottom) and T-Hg concentrations in blood of har-bour sealsFigur  1
Relationship between body mass (graph on top) and length (graph on the bottom) and T-Hg concentrations in 
blood of harbour seals.
Environmental Health 2008, 7:52 http://www.ehjournal.net/content/7/1/52The MTS assay (water soluble tetrazolium salts) reflects
cell proliferation and the metabolic activity of the
mitogen-stimulated lymphocytes. Metabolic activity was
significantly reduced compared to the controls at around
1 μM both for human and seal cells (Figure 5).
Detection of housekeeping gene and cytokines
In this set of experiments, seal PBMCs were cultured in the
presence of non-cytotoxic doses of MeHg (0.2 and 1 μM)
in order to examine mRNA expression. GAPDH, IL-2, IL-4
and TGF-β mRNA were successfully detected in both con-
trolled and exposed PBMCs (Figures 6, 7, 8). As a general
feature, change in mRNA expression occurred after expo-
sure: the number of copies decreased at 0.2 μM, except for
IL-4. The large dispersion of data between seals (coeffi-
cient of variation ≤ 68%) indicated high grade inter-indi-
vidual variability in cytokine mRNA responses. Cytokine
indexes were strikingly low for IL-2 and TGF-β even at 0.2
μM (Figures 6 and 7), while an increasing trend was
observed for IL-4 (Figure 8).
Proteomics analysis
Most of the proteins had an Ip of between 3 and 10. A
Mowse score was calculated for each identification, which
was considered as significant above 54 (Additional file 1).
Low doses of MeHg (1 μM) were found to affect cytoplas-
mic protein expression. Proteins are generally less
expressed in treated gels. Volume ratio (expression of pro-
tein in treated gel compared to control) was positive
(over-expression) for spot 1142 and spot 1452 but nega-
tive (lower-expression) for spots 1319 (vimentin), 897
and 923 (Table 2, Figures 9 and 10). These results showed
that the identified proteins are involved in many cellular
functions such as cell proliferation (SYW), the building of
the cytoskeleton (VIME), protein degradation (PRS10),
melatonin biosynthesis and the creation of transduction
pathways (GBLP, AN32A) (Additional file 1).
Discussion
In the present study, T-Hg concentrations in the blood of
harbour seals were found to vary widely, correlated to
length and body mass of the seals (Figure 1). The observed
correlation reflects daily Hg intake and thus, the amount
of fish ingested, which differs according the body mass of
animals. Adult harbour seals eat 5% to 6% of their body
weight per day, up to 7 kg for big individuals [59,60]. T-
Hg levels measured in the blood of harbour seals caught
in the North Sea are higher than those previously
Response of control PBMCs to PHA after 72 h of stimulationFigure 2
Response of control PBMCs to PHA after 72 h of stimulation. Results are expressed as a percentage expressed rela-
tive to the initial 2.106 cells per ml of culture medium. PHA concentration: 5 and 1 μg.ml-1 for harbour seals and humans 
respectively.
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Environmental Health 2008, 7:52 http://www.ehjournal.net/content/7/1/52described in North Atlantic or in Arctic regions (Table 3)
[61-63]. Interestingly, the level of T-Hg in the blood of
harbour seals from the North Sea is not lower than that
encountered in other seal species 30 years ago. Similarly,
Hg levels have not decreased in Arctic biota despite the
recent reductions in emissions in North America and
Western Europe [4-6].
A commonly used reference interval for human beings is
0.6 – 59 μg.L-1[64,65]. Clear signs of Hg toxicity develop
in most individuals only at some point much higher than
the upper reference limit. The Environmental Protection
Agency (USA) has recommended that blood Hg levels
should not be higher than 5.8 μg.L-1, at least for the more
sensitive individuals such as pregnant women [17]. A
study of a human cohort with high fish consumption in
the Faroe Islands found a median cord blood concentra-
tion of 24 μg.L-1 [66]. Obviously, the harbour seals we
studied from the North Sea displayed higher concentra-
tions (mean Hg concentration = 172 μg.L-1, around 1
μM). Knowing that Hg is mainly under a methylated form
in the blood of marine mammals (up to 90%), questions
arise regarding the potential biochemical effects of these
Hg levels on harbour seals and human immune cells. To
tentatively answer this question, a set of in vitro experi-
ments were carried out on T-lymphocytes using low MeHg
exposure (around 1 μM).
We exposed harbour seal and human lymphocytes in vitro
to MeHg and we examined the effects on cell-mediated
immunity: cell mortality, synthesis of DNA, RNA and pro-
tein and metabolic activity. Cell mortality was reduced in
the interval 0.1–1 μM (Figure 3) both for human and seal
PHA-stimulated PBMCs. Up to 90% of cells exposed to 1
– 1.5 μM of MeHg remained alive. However, a clear sup-
pressive effect of MeHg on DNA, RNA and protein synthe-
sis in seal and human PBMCs was found to be present,
even at low concentrations. Protein synthesis seemed less
affected, probably due to a longer response time (Figure
4). Proliferation and metabolic activity reflected by MTS
assay confirmed that 1 μM was a critical concentration
with significantly reduced in vitro activity of human and
seal PBMCs relative to controls (Figure 5). No striking dif-
ference appeared between human and seal in vitro resist-
ance to MeHg. At higher concentrations, 5–10 μM, 75% of
cells remained alive, but metabolic activity dropped to
very low levels.
Cytokine expression also decreased following MeHg
exposure: IL-2 and TGF-β seemed highly sensitive to in
vitro MeHg exposure in regard to their dramatic decrease
in gene expression at 0.2 μM and 1 μM compared to con-
trols (Figures 6, 7, 8). However, large inter-individual var-
iability has previously been observed and cytokine
expression in seal PBMCs has been found to vary widely,
depending also on the duration of MeHg exposure [48]. A
decrease in PBMC IL-2 expression has also been docu-
Percentage of surviving cells estimated by Trypan blue coloration after 72 h of MeHg exposureFigure 3
Percentage of surviving cells estimated by Trypan blue coloration after 72 h of MeHg exposure. * p < 0.05; **, p 
< 0.01 relative to control PBMCs 100%. 5 wells per condition for both species. Humans: n = 8 for 0.1 μM and 1 μM; n = 3 for 
other concentrations. Harbour seals: n = 5 for 1 μM and n = 2 for other concentration.
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Effects of MeHg exposure concentration on DNA (3H-thymidine), RNA (3H-uridine) and proteins (3H-leucine) in PBMCsFigure 4
Effects of MeHg exposure concentration on DNA (3H-thymidine), RNA (3H-uridine) and proteins (3H-leucine) 
in PBMCs. Results from quadruplets (means of counts per minute ± standard deviation, n = 4) are expressed in percentages 
(control taken to be 100%).
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Environmental Health 2008, 7:52 http://www.ehjournal.net/content/7/1/52mented in harbour seals following in vitro exposure to
PHA and PCB [37], raising the possibility of additive
effects of MeHg and other organic pollutants.
IL-2 has a prime role in immune response, as it is respon-
sible for T-cell clonal expansion after antigen recognition.
IL-2 also increases synthesis of other T-cell cytokines, pro-
motes the proliferation and differentiation of NK cells,
and acts as a growth factor and stimulus for B-cell anti-
body synthesis. TGF-β is often considered as an anti-
inflammatory cytokine [67,68]. A variety of murine mod-
els have provided evidence that eliminating TGF-β or dis-
rupting its downstream signalling cascade leads to
inflammatory disease [69].
In contrast, in the present study, the cytokine index of IL-
4 showed an increasing trend from control to 1 μM (Fig-
ure 8). IL-4 is known to induce the differentiation of naive
helper T cells (Th0 cells) into Th2 cells. Similarly, Devos
et al. found that inorganic mercury (HgCl2) and MeHg
was capable of increasing IL-4 production in Con A-stim-
ulated human PBMC in vitro [70]. They also observed that
IL-4 production occurred in a dose-dependent fashion,
although MeHg was found to be much more potent than
inorganic mercury in inducing IL-4 production [70]. Fur-
thermore, they observed MeHg induced IL-4 production
at a similar range of concentrations to those found in our
own investigation (0.1–0.5 uM) [70].
These preliminary in vitro results suggest that MeHg could
induce a differentiation of naïve cells (increase of IL-4),
while T-lymphocyte clonal expansion is inhibited
(decrease of IL-2); a decrease in TGF-β suggests an increase
in inflammatory response and would require further
investigation such as through a polynuclear cell model.
Our findings are consistent with those of previous
researchers working with human and rodent systems and
support a hypothesis of contaminant-altered lymphocyte
function mediated (at least in part) by the disruption of
cytokine production (TH2 cells) [34,37,71,72]. Whether
this phenomenon has clinical relevance in marine mam-
mal populations remains to be determined.
Study of the proteome
Proteomics facilitates the identification of new biomark-
ers of chemical exposure and studies of mechanisms by
which protein modification contribute to the adverse
effects of environmental exposure [73,74]. The proteome
of T-lymphocytes is well known [75-77]. However, the
expression of proteins in MeHg-exposed T-lymphocytes
MTS activity of human and seal PBMC relative to MeHg exposureFigure 5
MTS activity of human and seal PBMC relative to MeHg exposure. * p < 0.05; **, p < 0.01 relative to control PBMCs 
100%. For humans: n = 7 for 0.1 μM and 1 μM; n = 3 for other concentrations. For harbour seals: n = 5 for 1 μM and n = 2 for 
other concentrations. 5 wells per condition for both species.
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Environmental Health 2008, 7:52 http://www.ehjournal.net/content/7/1/52has not yet been described. Our results showed that iden-
tified proteins are involved in many cellular functions
such as cell proliferation (SYW), the building of the
cytoskeleton (VIME), protein degradation (PRS10), mela-
tonin biosynthesis (ASML) and the creation of transduc-
tion pathways (GBLP, AN32A). Human lymphoid cells
are an important physiological source of melatonin,
which could be involved in the regulation of the human
immune system [78]. As a general feature, many spots are
underexpressed in exposed gels, reflecting the inhibition
of protein synthesis linked to MeHg toxicity. As for
cytokine mRNA expression, high variability between indi-
viduals was evidenced here contrasting with functional
tests displaying weaker inter-individual variations. This
feature raises several issues within the framework of indi-
vidual susceptibility to pollutants.
Some of the proteins identified here are in agreement with
previous research describing MeHg toxicity mechanisms
leading to cell death. MeHg exposure is known to induce
a rapid and sustained increase in intracellular calcium lev-
els [79,80]. The earliest detectable event following MeHg
exposure is a change in the level of mitochondria [81].
Exposure of T-Cells to MeHg chloride has been found to
cause a decrease in the overall size of mitochondria and
changes in the structure of the cristae, leading finally to
apoptosis. [81,82]. A previous study observed the expres-
sion and activation of different caspases after 16 h of treat-
ment with MeHg [82]. Caspases are cysteine proteases that
are essential for executing apoptosis and for degrading
vimentin [83,84]. The lower vimentin expression found
here in exposed MeHg lymphocytes agrees with this cas-
pase activation.
In this study, we found that exposure for 72 hours in vitro
to 1 μM of MeHg affected not only cell proliferation but
also many cellular functions such as the building of the
cytoskeleton, melatonin biosynthesis, the creation of sig-
nal transduction pathways and signal transcription. This
variability in affected cellular functions suggests various
toxicity pathways, depending on duration of exposure,
MeHg concentration, cell type and individual susceptibil-
ity. This study shows the potential of using a proteomics
approach in deciphering the intracellular changes in cells
exposed in vitro to MeHg.
Cytokine index of IL-2 mRNA in function of MeHg exposureFigure 6
Cytokine index of IL-2 mRNA in function of MeHg exposure. Results are expressed in mRNA copy numbers per 
GAPDH mRNA copy. The mean and standard deviation on the mean of four individuals, carried out in duplicate, are shown.
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Environmental Health 2008, 7:52 http://www.ehjournal.net/content/7/1/52Conclusion
The T-Hg level analysed in the blood of wild harbour seals
from the German North Sea are high compared to previ-
ous studies on marine mammals and humans. The T-Hg
level observed reflects both seal piscivorous habits and the
contamination of the North Sea. Our cell model revealed
an in vitro immunosuppressive effect of MeHg, even at low
concentrations (0.2 and 1 μM). Although the in vitro
approach utilised in this investigation represents an
extreme reductionism relative to the complex situation in
the intact organism, it can provide an insight into specific
effects of model agents. However, many questions are
raised. One is the biological relevance of these in vitro phe-
nomena. In this regard, concentrations of Hg that are
active in vitro are comparable to those found in seal blood.
A second question, related to the issue of potential biolog-
ical relevance, is whether increased levels of mercury in
seals are epidemiologically associated with immunologi-
cal alterations (e.g. epizootics). This question is debata-
ble, as the association between mercury and health is well
documented for humans but is less evident for marine
mammals, which are believed to be more resistant to Hg
exposure. Our results suggest that seal and human PBMCs
react in a comparable way to MeHg in vitro exposure with,
however, larger inter-individual variations. MeHg could
be an additional cofactor in the immunosuppressive pol-
lutant cocktail generally described in the blood of seals
and this therefore raises the possibility of additional addi-
tive effects in the marine mammal immune system.
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Cytokine Index of TGF-β mRNA in function of MeHg exposureFigure 7
Cytokine Index of TGF-β mRNA in function of MeHg exposure. Results are expressed in mRNA copy numbers per 
GAPDH mRNA copy. The mean and standard deviation on the mean of four individuals, carried out in duplicate, are shown.
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Cytokine Index of IL-4 mRNA in function of MeHg exposureFigure 8
Cytokine Index of IL-4 mRNA in function of MeHg exposure. Results are expressed in mRNA copy numbers per 
GAPDH mRNA copy. The mean and standard deviation on the mean of four individuals, carried out in duplicate, are shown.
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2D-Dige Gel with cytoplasmic proteins extracted from one human control and treated PBMCsFigure 9
2D-Dige Gel with cytoplasmic proteins extracted 
from one human control and treated PBMCs. Each of 
the 3 individuals were analysed separately. O: excised spot 
for further protein identification. IPG strip pH 3 to 10.
2D-Dige Gel with cytoplasmic proteins extracted from human control and treated PBMCsFigure 10
2D-Dige Gel with cytoplasmic proteins extracted 
from human control and treated PBMCs. Cytoplasmic 
proteins extracted from 3 individuals were pooled for this 
gel. O: excised spot for further protein identification. IPG 
strip pH 3 to 10.
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